
Renault USA has submitted a citizen petition to the FDA, calling for strict regulations on disposable e-cigarettes.
The company specifically mentioned Puff Bar and Elf Bar, citing concerns about the increasing usage of these products among young people.
The petition also calls for strengthening enforcement of single-use products by increasing retail inspections and seizing such products at the US border.
Matthew Meyers, the president of the Campaign for Tobacco-Free Kids in the United States, recently criticized Reynolds' citizen petition.
Matthew Meyers believes that tobacco giant Reynolds American's demand for the FDA to crack down on disposable e-cigarettes under the guise of concern for children is a shamelessly hypocritical act, as Reynolds' Vuse brand is the second most popular e-cigarette brand among minors.
Matthew Meyers also stated, "Vuse is marketing in a way that targets youth. Is Reynolds considering leaving the competition for the youth market?
Further reading:
Renault submits petition urging FDA to rigorously investigate disposable e-cigarette products.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.









